Luckily Kazia has pushed Paxalisib through so many trials and each use-case will delivery benefits to patients.
Once one indication is approved for use it will make it easier for any other application and we already know there is multiple different uses for which Kazaa’s Paxalisib is currently in trials.
Still waiting on data - every single day brings us 8 days closer to data across 8 different trials for Paxalisib alone.
KZA Price at posting:
14.0¢ Sentiment: Buy Disclosure: Held
